The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
ICDDCE 2021: 15. International Conference on Drug Discovery in Cancer Epigenetics
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Drug Discovery in Cancer Epigenetics.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Drug Discovery in Cancer Epigenetics
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Drug Discovery in Cancer Epigenetics are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
OpenAIRE,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
ICDDCE 2021 has teamed up with the Special Journal Issue on
Drug Discovery in Cancer Epigenetics.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Digital Program consists of the e-proceedings book which is available online-only
and includes the conference communications (proceedings abstracts and papers).
Registered participants can access the digitally available conference
proceedings ( and certificates ) by visiting their profile pages.
Drug discovery in cancer epigenetics
Epigenetic mechanisms and phenomena
Cancer epigenetics
Methods and tools for epigenetic drug development
Drug discovery methods
Preclinical cancer models and clinical response
Discovery of biomarkers for drug development
Networks and consortia for epigenetic drug discovery
Classes of epigenetic drugs
DNA Methyltransferase Inhibitors
Small molecule inhibitors of Histone Deacetylases and Acetyltransferases
The development of selective methyltransferase and demethylase inhibitors
Bromodomains as anti-cancer targets
Epigenetic readers interpreting the Lysine Methylome
Non coding RNAs: clinical and therapeutic applications
Clinical implications of epigenetic therapy
Clinical applications of epigenetic drugs
Efficacy of combined epigenetic therapies
Predicting and monitoring responses to epigenetic drugs
Episensitization
The emerging potential for epigenetic therapeutics in non-cancer disorders
Abstracts/Full-Text Paper Submission Deadline |
|
February 15, 2021 |
Notification of Acceptance/Rejection |
|
March 01, 2021 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
February 14, 2021 |
Conference Dates |
|
March 25-26, 2021 |
Sivaramakrishna Yadavalli |
University of Houston, US |
Kal Ramnarayan |
Sapient Discovery, US |
Zhengwu Lu |
Abbott Laboratories, US |
Shweta Rajoriya |
Nanaji Deshmukh Veterinary Science University, IN |
Amina Ibrahim |
Kumamoto University , JP |
Shubhita Mathur |
Jaipur National University, IN |
Sudhir Sahdev |
Institute of Learning and Management, College of Engineering, IN |
Sheraz Gul |
Fraunhofer IME-SP, DE |
Gowri Meiyazhagan |
Periyar University, IN |
Emmanuel Oladayo Olawode |
Rhodes University, ZA |
Moulay Alaoui-Jamali |
McGill University, CA |
Yogesh Dalvi |
Pushpagiri Institute of Medical Sciences and Research Centre, IN |
Sridhar Radhakrishnan |
National University of Singapore, SG |
Srinivas Reddy Malladi |
Vaageswari College of Pharmacy, IN |
Hum Nath Jnawali |
Konkuk University, KR |
HAMENT PANWAR |
N.I.T., IN |
Zafar Iqbal |
The University of Agriculture Peshawar, PK |
Neeraj Upmanyu |
SCHOOL OF PHARMACY & RESEARCH, IN |
K.C.Venkatesh Babu |
Vinayaka Missions University, IN |
Anand Thirupathy |
PRIST Univesity, IN |
USHA RAJAMANICKAM |
Karpagam University, IN |
Asha Chaubey |
Indian Institute of Integrative Medicine Jammu, IN |
Saeedul Hassan |
University of the Punjab, PK |
Wayne Mitchell |
Experimental Therapeutics Centre, SG |
Shamsul Muhamad |
Institute for Medical Research, MY |
Kumaresan K |
Kumaraguru College of Technology, IN |
Deepshikha Pande Katare |
Amity University, IN |
VINOTH KUMAR THIRUMALAI RAJ |
Faculty of Medical technology, LY |
Karthikeyan Muthusamy |
Alagappa University, IN |
Participation Type |
Early Registration Ticket Fees |
Registration Ticket Fees |
Non-Student Oral/Poster Presenter Registration |
€ 450 |
€ 500 |
Student Oral/Poster Presenter Registration |
€ 350 |
€ 400 |
Listener Registration |
€ 250 |
€ 300 |
Additional Paper Publication |
€ 100 |
All conference materials and services will be delivered digitally to the participant with the online conference management system.
Conference registration includes the following digital materials and services:
- e-certificates [for Authors: Certificate of Attendance and Presentation; for Listeners: Certificate of Attendance; for Chairs: Certificate of Attendance and Appreciation; for Presenters: Certificate of Best Presentation (if conferred based appraisal)]
- e-program
- e-book
- e-name badge
- e-receipt
- e-presentation
Presentation Types:
-
Physical presentation is an oral conferencing presentation that is made using digital technology including embedded digital elements ( texts, tables, graphs, or videos ) for PowerPoint sharing.
-
Digital presentation is a digital conferencing presentation that is made using digital technology including embedded digital elements ( texts, tables, graphs, or videos ) for PowerPoint sharing.
Early Bird Registration
Early Bird registration was valid until 2021-02-14 23:59:59
Online Credit Card Processing
Online payment option available for author
and listener delegates.
Conference participants can make online credit card payments for conference registration fees.